Xenografts were conducted to ascertain whether SAMSN1 expression affected the intramedullary growth of human MM cells in long bones, and/or whether SAMSN1 would reduce the ability of the myeloma cells to form distal metastases. This evidence concerns the gene SAMSN1 and Miyoshi myopathy.